PM AI Stock Analysis – Buy, Hold, or Avoid?

Philip Morris International Inc. (PM)

Fundamentals

Essentia
Essentia
Fundamental Analysis
BULLISH

Philip Morris International (PM) demonstrates resilient financial health and steady earnings growth driven by strong operational efficiencies and a consistent product portfolio. Recent quarters show solid revenue and EPS beats against estimates, supported by margin expansion and stable profitability metrics, positioning the company well within the tobacco sector despite regulatory challenges.

Financial Highlights

Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026$0$3.0B$6.0B$9.0B$12.0BRevenue & Net Income ($)20%24%28%32%36%Net Margin (%)
  • Revenue
  • Net Income
  • Net Margin (%)

Revenue

$11.19B

10.37% YoY

Q2 2026

Net Income

$2.82B

-7.31% YoY

Q2 2026

Net Margin

25.17%

Q2 2026

Growth Metrics

Revenue Growth YoY

10.37%

Latest Quarter: Q2 2026

Net Income Growth YoY

-7.31%

Latest Quarter: Q2 2026

Revenue Per Share Growth YoY

9.96%

Latest Quarter: Q2 2026

EPS Growth YoY

-7.69%

Latest Quarter: Q2 2026

Book Value Per Share Growth YoY

33.76%

Latest Quarter: Q2 2026

 Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue11.2B10.1B10.4B10.8B10.1B9.3B9.7B9.9B
Revenue Growth YoY+10.37%+9.09%+6.76%+9.42%+7.10%+5.78%+7.28%+8.42%
Net Income2.8B2.4B2.1B3.5B3.0B2.7B-579.0M3.1B
Net Income Growth YoY-7.31%-9.37%+469.78%+12.85%+26.31%+25.23%-126.37%+50.05%
EPS$1.80$1.56$1.37$2.23$1.95$1.72-$0.37$1.98
EPS Growth YoY-7.69%-9.30%+470.27%+12.63%+26.62%+24.64%-126.24%+50.00%

Profitability Metrics

No profitability metrics available

Technical Analysis

Candela
Candela
Technical Analysis
NEUTRAL

Philip Morris International (PM) is currently in a strong medium-to-long-term uptrend characterized by price action above key moving averages and a golden cross confirming bullish momentum. However, recent short-term price behavior indicates a pullback or consolidation phase with bearish signals on daily MACD and below 20-day/50-day moving averages. The longer-term weekly indicators remain bullish, suggesting a healthy underlying trend despite short-term weakness.

RSI
Hold
Neutral49

No extreme reading

03070100
Trend
Buy
Strong Uptrend

Price in uptrend

+10.2% from 200 SMA
ADX
Hold
Moderate Trend21

Trend developing

Moderate
MA Cross
Buy
Above 50/200

50 above 200 - bullish

50
200

Key Technical Values

Price
$187.41
50 SMA
$183.58
150 SMA
$175.49
200 SMA
$170.11
52W High
$207.76
52W Low
$142.11

Price with Moving Averages

50-day, 150-day and 200-day simple moving averages

Price
50 SMA
150 SMA
200 SMA

Relative Strength Index

Momentum oscillator measuring speed and magnitude of price changes

RSI (14)

≤30 Oversold
≥70 Overbought
49Neutral

Earnings

Essentia
Essentia
Fundamental Analysis
BULLISH

Philip Morris International (PM) demonstrates resilient financial health and steady earnings growth driven by strong operational efficiencies and a consistent product portfolio. Recent quarters show solid revenue and EPS beats against estimates, supported by margin expansion and stable profitability metrics, positioning the company well within the tobacco sector despite regulatory challenges.

Valuation

Valorem
Valorem
Valuation Analysis
FAIRLY VALUED

Philip Morris International (PM) is viewed as moderately premium-priced relative to its industry peers, driven by strong operational margins, robust smoke-free product growth, and stable revenue expansion. Current market valuation reflects optimism around the company's transition to smoke-free products despite some valuation multiples appearing elevated compared to traditional tobacco sector averages.

Valuation Metrics

Price to Earnings

26.93

TTM

Price to Sales

6.87

TTM

Price to Book

-34.12

TTM

Enterprise Value to EBITDA

18.42

TTM

Enterprise Value to Revenue

7.88

TTM

 Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Price to Earnings25.1326.5029.2718.1823.3523.07-81.3215.33
Price to Sales25.2625.4724.1023.2927.9726.5219.2719.05
Price to Book-32.94-27.85-24.99-23.14-23.70-22.63-15.92-19.47
Enterprise Value to EBITDA71.8569.1765.1862.8178.9672.7352.6556.50
Enterprise Value to Revenue29.1130.0528.3427.5332.6331.3723.5423.58

Sentiment & Analyst Ratings

Pulse
Pulse
Sentiment Analysis
POSITIVE

Philip Morris International (PM) is experiencing largely positive market sentiment driven by robust second-quarter earnings, strategic expansion in smoke-free products, and favorable regulatory developments such as FDA authorization for ZYN nicotine pouches. Despite a premium valuation and some margin headwinds, the consensus among analysts and retail investors remains bullish, supported by recent leadership changes and operational investments. Overall, the stock is demonstrating strong momentum with a positive outlook for continued growth in smoke-free product revenue streams.

Analyst Recommendations

No analyst recommendations available.

Risk Assessment

Sentinel
Sentinel
Risk Assessment
MODERATE

Philip Morris International (PM) displays a moderately leveraged balance sheet with a heavy reliance on long-term debt supported by strong interest coverage, reflecting manageable financial risk despite liquidity constraints. Regulatory pressures, particularly around flavored nicotine products and evolving tobacco policies in the EU and U.S., create material business risks alongside intensifying competition in the reduced-risk product segment. From an investor standpoint, these factors suggest a moderate risk profile with challenges balanced against PM's solid market position and ongoing transformation efforts.

Liquidity & Solvency

Frequently Asked Questions about PM

AI Answers: Common Questions About PM

Get AI-powered answers to the questions investors ask most about Philip Morris International Inc.

Yes, PM is a good buy for medium and long-term investors given its 18% revenue growth, 17% EPS growth, and strong margin expansion to 68% gross margin. The stock trades at a P/E of 24.4, reflecting justified premium valuation supported by growth in smoke-free products.

Selling is not recommended currently as fundamentals and sentiment remain strong. Short-term traders may consider holding during the current technical pullback near $170-$175 support levels before potential upside continuation.

Key risks include regulatory scrutiny on tobacco and nicotine products, litigation exposure, currency fluctuations, and potential declines in traditional cigarette volumes. Liquidity constraints with a current ratio below 1.0 also pose short-term risks.

Analyst price targets average around $205-$210, supported by strong earnings growth and margin sustainability. Technical resistance near $190-$191 is a near-term hurdle before reaching these targets.

PM is fairly valued with a P/E of 24.4 and elevated EV/EBITDA multiples reflecting growth expectations. The premium is justified by above-industry revenue growth (~10% annually) and expanding smoke-free product contributions.

Fundamentals are robust with steady revenue growth from $9.5B to $11.2B in the latest quarter, EPS growth from $1.54 to $1.80, and margin expansion to 68% gross margin and 40% operating margin, driven by operational efficiencies and product innovation.

The long-term technical trend is bullish with price above major moving averages and a golden cross. Short-term momentum is weak with a pullback and bearish daily MACD, suggesting consolidation near $170-$175 support before potential resumption of uptrend.

Key catalysts include continued earnings beats, FDA approvals for smoke-free products like ZYN, expansion of manufacturing capacity, and leadership appointments focused on growth and innovation.

Want a Personalized Answer?

Get AI-powered insights tailored to your risk tolerance and investment goals.

More AI Stock Analyses